ALICIA EUGENE KIM
Eye and Vision Services Providers|Optometrist PHILADELPHIA, PA NPI 1922415306
Browse related groups: Eye and Vision Services Providers|Optometrist PA Tarsus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,066.44
- Category: General Payments
- Program years: PY2018–2024
- Record count: 40
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $228.88 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $228.88 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | $162.25 | 5 |
| Dompe US, Inc. | $32.45 | 1 |
| BIOTISSUE HOLDINGS INC. | $17.36 | 1 |
| Oyster Point Pharma, Inc. | $16.82 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1139108057 | Tarsus Pharmaceuticals, Inc. | $24.34 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139108059 | Tarsus Pharmaceuticals, Inc. | $39.50 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139108061 | Tarsus Pharmaceuticals, Inc. | $19.08 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139108063 | Tarsus Pharmaceuticals, Inc. | $46.23 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139108065 | Tarsus Pharmaceuticals, Inc. | $33.10 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147414476 | Oyster Point Pharma, Inc. | $16.82 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148754564 | BIOTISSUE HOLDINGS INC. | $17.36 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151396715 | Dompe US, Inc. | $32.45 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.